Lark Well being, CVS Caremark accomplice for cardiometabolic care

Persistent illness prevention and administration platform Lark Well being introduced it will likely be out there by means of CVS Caremark’s Level Options Administration program.

CVS Caremark prospects can have the power to entry Lark’s teaching packages, together with the corporate’s GLP-1 price containment and weight problems administration choices, by means of CVS Caremark’s platform.

In a LinkedIn submit, Lark mentioned it can tailor a holistic program that’s scalable, out there 24/7 and constructed upon particular employer wants, together with medical price financial savings, habits change-driven weight reduction options for applicable members and predictive modeling to extend insights into customized GLP-1 administration and commencement.

Lark Well being provides packages to assist forestall and handle hypertension and diabetes. The Lark app can be utilized with related units, comparable to scales, blood stress displays and blood glucose displays. The app may also be used to speak with Lark coaches.

“Employers are responding to super demand for GLP-1 drugs and weight administration amongst staff and given the prices of those medicine, they want versatile options that match their members’ wants,” Julia Hu, Lark Well being CEO and cofounder, mentioned on LinkedIn.

THE LARGER TREND

In 2024, Lark Well being appointed Darren Eckberg as chief progress officer to supervise the enlargement of the corporate’s AI-enabled GLP-1 cost-containment know-how. 

Eckberg beforehand held govt positions at EnvisionRx/Ceremony Help, Specific Scripts, Prime Therapeutics and IngenioRx/Anthem. 

In 2022, Lark Well being developed an AI-enabled platform aimed toward stopping and managing atherosclerotic heart problems and coronary artery illness in partnership with Roche Diagnostics.

In 2021, Lark Well being secured $100 million in a Collection D funding spherical. Deerfield Administration Firm led the increase, with participation from PFM Well being Sciences and returning traders Franklin Templeton, King River Capital, Castlepeak, IPD, Olive Tree Capital and Marvell Expertise cofounder Weili Dai.